Loading…

Cytokines serum levels as the markers of thyroid activation in Graves' disease

In order to examine which cytokine could be used as a marker of the biological effect of thyroid hormones or anti-thyroid antibodies in Graves' disease (GD) patients, we simultaneously evaluated the concentrations of TSH, free thyroid hormones (fT 3 and fT 4), anti-thyroid antibodies (anti-TPO...

Full description

Saved in:
Bibliographic Details
Published in:Immunology letters 1998-02, Vol.60 (2), p.143-148
Main Authors: Komorowski, Jan, Jankiewicz, Joanna, Robak, Tadeusz, Błasińska-Morawiec, Maria, Stępień, Henryk
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In order to examine which cytokine could be used as a marker of the biological effect of thyroid hormones or anti-thyroid antibodies in Graves' disease (GD) patients, we simultaneously evaluated the concentrations of TSH, free thyroid hormones (fT 3 and fT 4), anti-thyroid antibodies (anti-TPO and anti-TG) and a group of cytokines: interleukin-2 (IL-2), tumour necrosis factor α (TNF α), interleukin-6 (IL-6) and their soluble receptors (sIL-2R, sTNF αR, sIL-6R) as well as interleukin-10 (IL-10) in eight GD females and nine normal controls. We found that serum sIL-2R concentrations of GD patients had only the tendency to be higher versus controls, but strong positive correlations between fT 3 and fT 4 and sIL-2R in peripheral blood of GD subjects were revealed. We showed that sIL-2R was the best cytokine marker, showing very good correlation with the endocrine status of GD patients.
ISSN:0165-2478
1879-0542
DOI:10.1016/S0165-2478(97)00151-X